Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2005
06/16/2005CA2546820A1 Derivatives of dihydronepetalactone and method for preparation
06/16/2005CA2546784A1 Glycomimetic antagonists for both e- and p-selectins
06/16/2005CA2546782A1 Pharmaceutical uses of bisphosphonates
06/16/2005CA2546738A1 Pharmaceutical combinations
06/16/2005CA2546682A1 Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides and use as renin inhibitors
06/16/2005CA2546657A1 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
06/16/2005CA2546653A1 3-aminopyrrolidone derivatives
06/16/2005CA2546647A1 Antidiabetic compounds comprising benzofuran and benzothiophene derivatives
06/16/2005CA2546445A1 Use of beta-lapachone for protecting against radiation injury
06/16/2005CA2546292A1 Enoxaparin for the treatment of cancer
06/16/2005CA2546247A1 Ppar agonists for the treatment of hcv infection
06/16/2005CA2546117A1 1h-imidazoquinoline derivatives as protein kinase inhibitors
06/16/2005CA2545992A1 Pyrazolyl and imidazolyl pyrimidines
06/16/2005CA2545609A1 Antimicrobial compositions comprising polymeric stabilizers
06/16/2005CA2545589A1 Phosphinic acid derivatives
06/16/2005CA2545582A1 5-(benz-(z)-ylidene)-thiazolidin-4-one derivatives as immunosuppressant agents
06/16/2005CA2545543A1 Novel use of peptide compounds for treating central neuropathic pain
06/16/2005CA2545425A1 Azole-based kinase inhibitors
06/16/2005CA2545422A1 Tubulin inhibitors
06/16/2005CA2545271A1 Association of antimicrobial compounds with surfaces and polymers
06/16/2005CA2545140A1 Use of ppar activators in cosmetics and dermatology
06/16/2005CA2543577A1 Sprayable composition for the administration of vitamin d derivatives
06/16/2005CA2543090A1 Nucleoside compounds for treating viral infections
06/16/2005CA2541691A1 1h-imidazo[4,5-c]quinoline derivatives in the treatment of protein kinase dependent diseases
06/16/2005CA2539575A1 Method of removing transition metals, especially from metathesis reaction products
06/16/2005CA2536393A1 Use of liposomes which are small unilamellar vesicles for the removal of an entity from a biological sample
06/15/2005EP1541587A2 Method for down-regulating osteoprotegerin ligand activity
06/15/2005EP1541580A1 Sulfotransferase inhibitors
06/15/2005EP1541578A1 Process for selective production of aryl 5-thio-beta-d-aldohexopyranosides
06/15/2005EP1541576A1 Furoisoquinoline derivative and use thereof
06/15/2005EP1541573A1 Novel crystals of triazaspiro 5.5 undecane derivative
06/15/2005EP1541572A1 Thioether substituted imidazoquinolines
06/15/2005EP1541563A1 Ccr4 antagonist and medicinal use thereof
06/15/2005EP1541562A1 Novel uracil derivatives and medicinal use thereof
06/15/2005EP1541559A1 5-substituted isoquinoline derivative
06/15/2005EP1541554A1 Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same
06/15/2005EP1541553A1 Novel indoline compound and medicinal use thereof
06/15/2005EP1541551A1 2-cyano-4-fluoropyrrolidine derivative or its salt
06/15/2005EP1541547A1 Hydroxylamine derivatives
06/15/2005EP1541546A1 Crystal of amino acid ester salt and process for producing the same
06/15/2005EP1541544A1 Method of preparing hydroxytyrosol esters, esters thus obtained and use of same
06/15/2005EP1541197A1 Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
06/15/2005EP1541177A1 Adhesive patch
06/15/2005EP1541176A1 Adhesive patch
06/15/2005EP1541175A2 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions
06/15/2005EP1541174A1 Drug or cosmetic
06/15/2005EP1541172A1 Remedy for intestinal diseases and visceral pain
06/15/2005EP1541170A1 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
06/15/2005EP1541168A1 Method of regulating animal reproduction
06/15/2005EP1541164A1 Combination of licochalcone A or an extract of radix glycyrrhizae inflatae, comprising licochalcone A, phenoxyethanol and if required glycerin
06/15/2005EP1541154A1 Medicinal composition for drug-induced neuropathy
06/15/2005EP1541153A1 Hepatitis c virus inhibitor comprising alpha-glycosylceramide as the active ingredient
06/15/2005EP1541152A1 Combination of a phytosterol and/or cholesterol and licochalcone A or an aqueous extract of Glyzyrrhizae inflata radix comprising licochalcone A
06/15/2005EP1541151A1 REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND PROSTAGLANDINS
06/15/2005EP1541150A1 Use of methylol transfer agents for treatment of mesothelioma
06/15/2005EP1541149A1 Phosphodiesterase inhibitor
06/15/2005EP1541147A1 Improved delivery of multiple doses of a methylphenidate drug
06/15/2005EP1541146A1 Zolpidem hemitartrate solvate
06/15/2005EP1541145A1 The use of benzisoselenazolone compounds against ischemic myocardial damage
06/15/2005EP1541144A1 Indometacin preparation for external use
06/15/2005EP1541142A1 Pharmaceutical compositions containing platinum complexes with secondary xanthates and therapeutic uses thereof
06/15/2005EP1541141A1 Therapeutic agent for hepatic disease
06/15/2005EP1541140A1 Amino acid-containing chewable
06/15/2005EP1541139A1 Drug composition containing nf-kappa b inhibitor
06/15/2005EP1541138A1 Novel use of peptide compounds for treating status epilepticus or related conditions
06/15/2005EP1541137A2 Transdermal delivery system of hormones without penetration enhancers
06/15/2005EP1541136A1 UV light-stable semi-solid transdermal systems comprising a photosensitive active agent and an UV-absorbing component
06/15/2005EP1541134A2 Stabilized azithromycin compositions
06/15/2005EP1541133A1 Pharmaceutical formulation of valaciclovir
06/15/2005EP1541129A1 Pharmaceutical effervescent formulation comprising amoxycillin and clavulanic acid
06/15/2005EP1541128A2 Cosmetic composition containing derivatives of cinnamic acid and its use
06/15/2005EP1541125A1 Spreadable compositions for topical use, a process of making same and uses thereof
06/15/2005EP1541041A1 Pharmaceutical and/or dietary compositions against stress
06/15/2005EP1541037A1 Oral composition containing extracts of Passiflora incarnata
06/15/2005EP1540341A1 Method for determination of likelihood of occurrence of preterm labor in pregnant females
06/15/2005EP1540338A1 Bioequivalence test for iron-containing formulations
06/15/2005EP1540332A1 Methods of screening compounds for grk6 modulating activity
06/15/2005EP1540012A2 Polymorphisms for predicting disease and treatment outcome
06/15/2005EP1539978A1 Method of isolating biologically active fraction containing clinically acceptable native slipopolysaccharides obtained from bacteria producing endotoxic lipopolysaccharides
06/15/2005EP1539977A2 Tiacumicin production
06/15/2005EP1539971A1 Her-2/neu dna vaccine having anti-cancer activity
06/15/2005EP1539962A1 Polyene polyketides and methods of production
06/15/2005EP1539957A1 Novel diagnostic and therapeutic methods and reagents therefor
06/15/2005EP1539942A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
06/15/2005EP1539933A2 Methods of organ regeneration
06/15/2005EP1539819A2 Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells
06/15/2005EP1539811A2 Production of bispecific molecules using polyethylene glycol linkers
06/15/2005EP1539799A2 Crosslinked compounds and methods of making and using thereof
06/15/2005EP1539796A1 Anti-inflammatory or anti-allergic androstane complexes
06/15/2005EP1539795A1 Crystalline 17beta-hydroxy-7alpha-(5'-methyl-2'-furyl)-pregna-4,9(11)-dien-3-one-21-carboxylic acid, gamma-lactone
06/15/2005EP1539780A1 Derivatives of monosaccharides for drug discovery
06/15/2005EP1539769A1 Bicyclic heteroaromatic compounds as kinase inhibitors
06/15/2005EP1539766A1 Calcitonin gene related peptide receptor antagonists
06/15/2005EP1539765A1 Biaryl diazabicycloalkane amides as nicotinic acetylcholine agonists
06/15/2005EP1539764A1 Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists.
06/15/2005EP1539763A1 Azaindole kinase inhibitors
06/15/2005EP1539762A2 Bicyclic pyrimidinones as coagulation cascade inhibitors
06/15/2005EP1539759A1 Use of and some novel imidazopyridines
06/15/2005EP1539758A1 Substituted pyrrolopyridines
06/15/2005EP1539757A1 Substituted pyrrolopyridines
1 ... 4652 4653 4654 4655 4656 4657 4658 4659 4660 4661 4662 4663 4664 4665 4666 4667 4668 4669 4670 4671 4672 ... 7860